Fundz

Lantern Pharma reported raising $535,000 in an initial SEC Form D filing, from an offering of $535,000

PUBLIC · LTRNJan 14, 2019

Amount Raised

$535,000

$535,000 sold, per SEC Form D (first sale Jan 14, 2019)

Round Type

Seed

DallasBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Lantern Pharma that raised within 45 days of this round, from Fundz verified event records.

  • NemaMetrix Inc. raised $5.2M on February 27, 2019.
  • Savran Technologies raised $25K (Pre-Seed) on February 27, 2019.
  • Geneos Therapeutics raised $4.5M (Seed) on February 27, 2019.
  • HOOKIPA Pharma raised $37M on February 27, 2019.
  • Knopp Biosciences LLC raised $10M on February 27, 2019.
  • GENOCEA BIOSCIENCES, INC. raised $12M on February 27, 2019.

Who to call at Lantern Pharma, and when

A new round usually means Lantern Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lantern Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lantern Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lantern Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lantern Pharma

Location

1920 MCKINNEY AVENUE

Dallas, Texas, United States

About

Lantern develop novel targeted cancer therapeutics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lantern Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Lantern Pharma's next move

See what Strategic adds

Lantern Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.